Akari Therapeutics And Peak Bio Announce Merger Of Equals; Exchange Is Expected To Result In Implied Equity Ownership In The Combined Company Of Approximately 50% For Akari Shareholders And Approximately 50% For Peak Stockholders
Akari Therapeutics和Peak Bio宣布对等合并；交易所预计将使合并后的公司的隐含股权为Akari股东约50％，Peak股东的隐含股权约为50％